XSHE
300019
Market cap806mUSD
Oct 09, Last price
15.60CNY
1D
13.62%
1Q
-22.43%
Jan 2017
13.54%
IPO
144.90%
Name
Chengdu Guibao Science & Technology Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in 1998 and based in Chengdu, China, Chengdu Guibao Science & Technology Co.,Ltd. specializes in the production and distribution of organic silicone sealants and silicone rubber strips across the People's Republic of China. Their diverse product line includes sealants designed for various applications such as curtain walls, insulating glass, windows and doors, interior finishing, concrete joints, automotive lighting, solar modules, and corrosion prevention, as well as silicone gaskets and industrial adhesives suitable for infrastructure projects like roads and bridges. The company also conducts research, development, and sales of silane coupling agents. Furthermore, Guibao offers related consulting services, provides solutions for home furnishings and decor, engages in the wholesale and retail of silicone rubber products, and is involved in the design, construction, and contracting of anti-corrosion system solutions.
Key people
Youzhi Wang
Chairman of the Board · since 2022
Qiang Huang
Deputy General Manager · since 2017
Guoli Li
Deputy General Manager · since 2025
Song Li
Chief Financial Officer, Deputy General Manager · since 2025
Xiaofeng Luo
Deputy General Manager · since 2019
Pandeng Yang
Deputy General Manager · since 2025
Chengxi Zhang
Deputy General Manager · since 2025
Yuanyuan Li
Deputy General Manager, Secretary of the Board · since 2025
Bin Guo
Director · since 2012
Youqiang Wang
Vice Chairman of the Board, Staff Elected Director · since 2025
Director · since 2025
Independent Director · since 2022
Yang Yi
Independent Director · since 2025
Headquarters & legal address
成都高新区新园大道16号
成都市, SC 610000
CN
成都市, SC 610000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||